Evaluation of the cytokines IL-10 and IL-13 as mediators in the progression of symmers fibrosis in patients with hepatosplenic schistosomiasis mansoni;Avaliação das citocinas IL-10 e IL-13 como mediadores na progressão da fibrose de symmers em portadores de esquistossomose mansônica na forma hepatoesplênica

Revista do Colegio Brasileiro de Cirurgioes

Volumn 37, Issue 5, 2010, Pages 333-337

  Brandt, Carlos Teixeira ^a   Rino, Mario ^a   da Rocha Pitta, Maira Galdino ^a   Muniz, Janinne Siqueira ^a   de Oliveira Silveira, Diego ^a   de Castro, Célia Maria Machado Barbosa ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Interleukin; Interleukin 10; Schistosomiasis mansoni; Spleen; Splenectomy

Indexed keywords

EID: 78650813365     PISSN: 01006991     EISSN: 18094546     Source Type: Journal    
DOI: 10.1590/s0100-69912010000500005     Document Type: Article

References (27)

1. World Health Organization [Internet]. Switzerland: WHO; c2009 [cited 2009 Apr 10]. Available from: http://www.who.int/en/
2. Amaral RS, Tauil PL, Lima DD, Engels D. An analysis of the impact of the Schistosomiasis Control Programme in Brazil. Mem Inst Oswaldo Cruz. 2006; 101 Suppl 1:79-85.
3. Favre TC, Ximenes RA, Galvao AF, Pereira AP, Wanderlei TN, Barbosa CS, et al. Reliability of current estimates of schistosomiasis prevalence in the Rainforest Zone of the state of Pernambuco, Northeastern Brazil. Mem Inst Oswaldo Cruz. 2006; 101 Suppl 1:73- 8.
4. Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, Camilla C, et al. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol. 2002;169(2):929-36.
5. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med. 2000;21(3):49-98.
6. Ramadori G, Knittel T and Saile B. Fibrosis and altered matrix synthesis. Digestion. 1998;59(4):372-5.
7. Pinzani M. Novel insights into the biology and physiology of the Ito cell. Pharmacol Ther. 1995;66(2):387-412.
8. Tamai K, Ishikawa H, Mauviel A, Uitto J. Interferon-gamma coordinately upregulates matrix metalloprotease (MMP)-1 and MMP-3, but not tissue inhibitor of metalloproteases (TIMP), expression in cultured keratinocytes. J Invest Dermatol. 1995;104(3):384-90.
9. Kaviratne M, Hesse M, Leusink M, Cheever AW, Davies SJ, McKerrow JH, et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol. 2004;173(6):4020-9.
10. Tiggelman AM, Boers W, Linthorst C, Sala M, Chamuleau RA. Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma. J Hepatol. 1995;23(3):307-17.
11. Booth M, Mwatha JK, Joseph S, Jones FM, Kadzo H, Ireri E, et al. Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. J Immunol. 2004;172(2):1295-303.
12. de Jesus AR, Magalhães A, Miranda DG, Miranda RG, Araújo MI, de Jesus AA, et al. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun. 2004;72(6):3391-7.
13. Alves Oliveira LF, Moreno EC, Gazzinelli G, Martins-Filho OA, Silveira AM, Gazzinelli A, Malaquias LC, et al. Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans. Infect Immun. 2006;74(2):1215-21.
14. Watanabe K, Mwinzi PN, Black CL, Muok EM, Karanja DM, Secor WE, Colley DG. T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment. Am J Trop Med Hyg. 2007;77(4):676-82.
15. Mohamed-Ali Q, Elwali NE, Abdelhameed AA, Mergani A, Rahoud S, Elagib KE, et al. Susceptibility to periportal (Symmers) fibrosis in human schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J Infect Dis. 1999;180(4):1298-306.
16. Mola PW, Farah IO, Kariuki TM, Nyindo M, Blanton RE, King CL. Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment. Infect Immun. 1999;67(12):6565-71.
17. Dunn MA, Kamel R. Hepatic schistosomiasis. Hepatology. 1981;1(6):653-61.
18. Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol. 2000;164(5):2585-91.
19. Reiman RM, Thompson RW, Feng CG, Hari D, Knight R, Cheever AW, et al. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun. 2006; 74(3): 1471-1479.
20. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, Feingold J, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet. 1996;14(2):181-4.
21. Kouriba B, Chevillard C, Bream JH, Argiro L, Dessein H, Arnaud V, et al. Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections. J Immunol. 2005;174(10):6274-81.
22. Dessein AJ, Hillaire D, Elwali NE, Marquet S, Mohamed-Ali Q, Mirghani A, et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet. 1999;65(3):709-21.
23. Chevillard C, Moukoko CE, Elwali NE, Bream JH, Kouriba B, Argiro L, et al. IFN-gamma polymorphisms (IFN-gamma +2109 and IFN- gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol. 2003;171(10):5596-601.
24. Rachfal AW and Brigstock DR. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res. 2003;26(1):1-9.
25. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, Kolb M. Connective tissue growth factor is crucial to inducing a profibrotic environment in fibrosis-resistant BALB/c mouse lungs. Am J Respir Cell Mol Biol. 2004; 31(5):510-6. Epub 2004 Jul 15.
26. Chen MM, Lam A, Abraham JA, Schreiner GF and Joly AH. CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol. 2000;32(10):1805-19.
27. Dessein A, Chevillard C, Arnaud V, Hou X, Hamdoun AA, Dessein H, et al. Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese, and Brazilians infected with schistosomes. J Exp Med. 2009; 206(11): 2321-8. Epub 2009 Oct 12.